# Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

> **NCT05266898** · PHASE4 · RECRUITING · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 250 (estimated)

## Conditions studied

- Papillomavirus Vaccines
- Human Immunodeficiency Virus
- Papillomavirus Infection
- Serology
- Cervical Intraepithelial Neoplasia
- Anal Intraepithelial Neoplasia
- Oral Cavity Infection

## Interventions

- **BIOLOGICAL:** Human papillomavirus 9-valent vaccine, recombinant
- **BIOLOGICAL:** human papillomavirus vaccine, recombinant

## Key facts

- **NCT ID:** NCT05266898
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-30
- **Primary completion:** 2025-12
- **Final completion:** 2026-06
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266898, "Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05266898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*